Free In an Experiment, CMS Will Vary Part B Drug Payments by Providers’ ZIP Codes March 08, 2016By Paul Goldberg
Capitol HillFree Capitol Hill Briefing Focuses on Moonshot’s Provision to Integrate FDA Cancer Portfolio February 26, 2016Vol.42 No.08By Matthew Bin Han Ong
FreeNews Analysis Rejected Therapy Reveals Inconsistency of FDA Procedures for Drugs, Immunotherapies February 19, 2016Vol.42 No.07By Paul Goldberg
Conversation with The Cancer LetterFree Sigal: $75 Million Not Enough for FDA Reform February 12, 2016Vol.42 No.06
